Bank of America’s Vera Therapeutics VERA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.29M | Buy |
394,280
+167,264
| +74% | +$3.94M | ﹤0.01% | 2810 |
|
|
2025
Q1 | $5.45M | Buy |
227,016
+196,772
| +651% | +$4.73M | ﹤0.01% | 3141 |
|
|
2024
Q4 | $1.28M | Sell |
30,244
-106,673
| -78% | -$4.51M | ﹤0.01% | 4058 |
|
|
2024
Q3 | $6.05M | Sell |
136,917
-42,995
| -24% | -$1.9M | ﹤0.01% | 3036 |
|
|
2024
Q2 | $6.51M | Sell |
179,912
-20,240
| -10% | -$732K | ﹤0.01% | 2895 |
|
|
2024
Q1 | $8.63M | Buy |
200,152
+161,669
| +420% | +$6.97M | ﹤0.01% | 2659 |
|
|
2023
Q4 | $592K | Sell |
38,483
-56,633
| -60% | -$871K | ﹤0.01% | 4507 |
|
|
2023
Q3 | $1.3M | Buy |
95,116
+84,457
| +792% | +$1.16M | ﹤0.01% | 3844 |
|
|
2023
Q2 | $171K | Sell |
10,659
-77,178
| -88% | -$1.24M | ﹤0.01% | 5110 |
|
|
2023
Q1 | $682K | Buy |
87,837
+36,161
| +70% | +$281K | ﹤0.01% | 4425 |
|
|
2022
Q4 | $1,000K | Buy |
51,676
+17,279
| +50% | +$334K | ﹤0.01% | 4213 |
|
|
2022
Q3 | $733K | Buy |
34,397
+12,943
| +60% | +$276K | ﹤0.01% | 4397 |
|
|
2022
Q2 | $292K | Buy |
21,454
+5,850
| +37% | +$79.6K | ﹤0.01% | 5093 |
|
|
2022
Q1 | $367K | Buy |
15,604
+3,697
| +31% | +$87K | ﹤0.01% | 5313 |
|
|
2021
Q4 | $318K | Buy |
11,907
+5,386
| +83% | +$144K | ﹤0.01% | 5410 |
|
|
2021
Q3 | $113K | Buy |
6,521
+309
| +5% | +$5.36K | ﹤0.01% | 5793 |
|
|
2021
Q2 | $82K | Buy |
+6,212
| New | +$82K | ﹤0.01% | 5821 |
|